DANVERS, Mass.--(BUSINESS WIRE)--Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that the PROTECT II results have been accepted to be presented by William O’Neill, M.D., University of Miami, during the late-breaking clinical trials session at the American College of Cardiology (ACC) 2011 show.
